Food & Food Contact Materials
CIRS Group
Chemicals
Cosmetic
Food
Medical Devices
Agrochemicals
C&K Testing
Carbon Neutrality
Search

China CFE Releases Notice regarding the Registration Application for FSMP Proposed for Inclusion in the Priority Review and Approval Process (Notice No. 1 of 2024)

from CIRS by

640_wx_fmt=png&from=appmsg&tp=webp&wxfrom=5&wx_lazy=1&wx_co=1.webp

On April 3, 2024, in accordance with the Measures for the Registration of Food for Special Medical Purpose (Announcement No. 85) issued by the State Administration for Market Regulation (SAMR), the Center for Food Evaluation (CFE) has reviewed the registration applications for FSMP seeking priority review and approval, and is now making public the proposed FSMP for the priority process. The public notice period will be in effect for 5 working days.

Should there be any objections, interested parties are invited to submit written comments along with detailed reasons to the CFE during the notice period. Alternatively, scanned documents can be sent via email: tyyxsp@cfe-samr.org.cn.

Registration applications for FSMP proposed for priority review and approval

S.N.

Acceptance No.

Product name

Applicant

Category

Reasons for inclusion

1

国申注申TY20230077

纽康特壹加food protein allergy nutritionally complete food for special medical purpose

SHS International Ltd.

Specific nutritionally complete food

New food for special medical purposes in urgent clinical needs and not yet approved

2

国申注申TY20230080

拜膳平diabetes nutritionally complete food for special medical purpose

KWINS HEALTH

Specific nutritionally complete food

New food for special medical purposes in urgent clinical needs and not yet approved

If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.

Further information

SAMR Notice

  

We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.

Contact Us
+353 1 477 3710 (EU)
+44 20 3239 9430 (UK)
+1 703 520 1420 (USA)
+86 571 8720 6574 (CN)
+82 2 6347 8816 (KR)